Drug Shortage Report for EPINEPHRINE INJECTION USP

Last updated on 2025-04-02 History
Report ID 253333
Drug Identification Number 02435810
Brand name EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHRINE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1mL
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2025-04-01
Actual start date
Estimated end date 2025-05-15
Actual end date
Shortage status Actual shortage
Updated date 2025-04-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2025-04-02 English Compare
v2 2025-03-24 French Compare
v1 2025-03-24 English Compare

Showing 1 to 3 of 3